YD Bio (NASDAQ:YDES) Stock Price Down 9.1% – Should You Sell?

YD Bio Limited (NASDAQ:YDES)’s share price fell 9.1% during mid-day trading on Monday . The stock traded as low as $7.62 and last traded at $7.62. 8,043 shares traded hands during trading, a decline of 81% from the average session volume of 41,891 shares. The stock had previously closed at $8.38.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of YD Bio in a research report on Monday, December 29th. Wall Street Zen raised shares of YD Bio from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

YD Bio Stock Down 1.7%

The firm’s 50-day moving average is $10.71.

Hedge Funds Weigh In On YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC lifted its holdings in YD Bio Limited (NASDAQ:YDES) by 10.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent reporting period.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.